269 related articles for article (PubMed ID: 19320745)
1. Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.
Council ML; Gardner JM; Helms C; Liu Y; Cornelius LA; Bowcock AM
Exp Dermatol; 2009 May; 18(5):485-7. PubMed ID: 19320745
[TBL] [Abstract][Full Text] [Related]
2. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
3. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
[TBL] [Abstract][Full Text] [Related]
4. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
[TBL] [Abstract][Full Text] [Related]
5. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
[TBL] [Abstract][Full Text] [Related]
6. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
Ghiorzo P; Pastorino L; Pizzichetta MA; Bono R; Queirolo P; Talamini R; Annessi G; Bruno W; Nasti S; Gargiulo S; Battistuzzi L; Sini MC; Palmieri G; Scarrà GB;
Melanoma Res; 2009 Jun; 19(3):142-5. PubMed ID: 19339902
[TBL] [Abstract][Full Text] [Related]
8. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Pho L; Grossman D; Leachman SA
Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
[TBL] [Abstract][Full Text] [Related]
9. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
[TBL] [Abstract][Full Text] [Related]
10. Melanoma and genetics.
Nelson AA; Tsao H
Clin Dermatol; 2009; 27(1):46-52. PubMed ID: 19095153
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor variants and the malignant melanoma risk: a population-based study.
Gapska P; Scott RJ; Serrano-Fernandez P; Mirecka A; Rassoud I; Górski B; Cybulski C; Huzarski T; Byrski T; Nagay L; Maleszka R; Sulikowski M; Lubinski J; Debniak T
Cancer Epidemiol; 2009 Aug; 33(2):103-7. PubMed ID: 19679055
[TBL] [Abstract][Full Text] [Related]
12. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.
de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E
Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
[TBL] [Abstract][Full Text] [Related]
14. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
Eliason MJ; Hansen CB; Hart M; Porter-Gill P; Chen W; Sturm RA; Bowen G; Florell SR; Harris RM; Cannon-Albright LA; Swinyer L; Leachman SA
Arch Dermatol; 2007 Nov; 143(11):1409-12. PubMed ID: 18025365
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
Berwick M; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Busam K; From L; Mujumdar U; Wilcox H; Begg CB;
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1520-5. PubMed ID: 16896043
[TBL] [Abstract][Full Text] [Related]
16. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
Kanetsky PA; Rebbeck TR; Hummer AJ; Panossian S; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Culver HA; Zanetti R; Gallagher RP; Dwyer T; Busam K; From L; Mujumdar U; Wilcox H; Begg CB; Berwick M
Cancer Res; 2006 Sep; 66(18):9330-7. PubMed ID: 16982779
[TBL] [Abstract][Full Text] [Related]
17. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.
Kanetsky PA; Ge F; Najarian D; Swoyer J; Panossian S; Schuchter L; Holmes R; Guerry D; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):808-19. PubMed ID: 15159314
[TBL] [Abstract][Full Text] [Related]
18. Melanocortin-1 receptor: loss of function mutations and skin cancer.
Mumm CD; Draznin M
Dermatol Online J; 2006 Sep; 12(5):13. PubMed ID: 16962028
[TBL] [Abstract][Full Text] [Related]
19. High- and low-penetrance cutaneous melanoma susceptibility genes.
Fargnoli MC; Argenziano G; Zalaudek I; Peris K
Expert Rev Anticancer Ther; 2006 May; 6(5):657-70. PubMed ID: 16759158
[TBL] [Abstract][Full Text] [Related]
20. High incidence of primary melanomas in an MC1R RHC homozygote/CDKN2A mutant genotype patient.
Sinnya S; Jagirdar K; De'Ambrosis B; McMeniman E; Sturm RA; Soyer HP
Arch Dermatol Res; 2015 Oct; 307(8):741-5. PubMed ID: 26103950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]